ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

RGNX vs ENTX // GROSS PROFIT MARGIN

REGENXBIO Inc. (NASDAQ) VS. Entera Bio Ltd. (NASDAQ) • 15-METRIC TALLY: RGNX 2 — ENTX 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (RGNX VS. ENTX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC RGNX ENTX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin ACTIVE — 0.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -33.60% -1.40 ENTX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -1.38% — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 104.50% -65.00% +169.50 RGNX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 2/9 +2.00 RGNX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 49.6 59.4 -9.80 ENTX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $489.2M $542.6M -$53.5M ENTX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR RGNX REV ENTX REV RGNX GROSS % ENTX GROSS % RGNX FCF ENTX FCF
FY 2025 $170.4M $42.0K — 0.0% -$126.4M -$7.5M
FY 2024 $83.3M $181.0K 59.7% 5.0% -$175.6M -$6.8M
FY 2023 $90.2M $0 — — -$218.4M -$7.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
RGNX // BETA —
ENTX // BETA —